Bausch+Lomb News

Google News
  1. This RSS feed URL is deprecated, please update. New URLs can be found in the footers at

  2. Rochester Democrat and Chronicle

    Valeant to change name to Bausch Health Cos. in July
    Rochester Democrat and Chronicle
    This was the first time since 2015 that the company delivered overall organic revenue growth, based on success in the Branded Rx and Bausch and Lomb/International segments, he continued, which showed 8 percent and 2 percent organic revenue growth ...
    Valeant, Distancing Itself From Its Past, Will Change Its Name to Bausch HealthNew York Times
    Valeant Pharma reports quarterly loss, to change name to Bausch...CNBC
    Valeant Pharmaceuticals, which owns Bausch + Lomb owners, changes nameRochesterFirst
    MarketWatch -Investor's Business Daily -PharmaLive (press release) -Benzinga
    all 235 news articles »


    Bausch + Lomb Launches LUMIFY, The First And Only OTC...
    PR Newswire (press release)
    LAVAL, Quebec, May 7, 2018 /PRNewswire/ -- Bausch + Lomb Launches LUMIFY, The First And Only OTC Redness Relieving Eye Drop With Low-Dose ...
    CNW | Bausch + Lomb Launches LUMIFY, The First And Only OTC...Canada NewsWire (press release)

    all 2 news articles »

  4. Nasdaq

    Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for...
    PR Newswire (press release)
    Lenses Can Be Worn for Up to Six Nights and Seven Days Continuously. LAVAL, Quebec, May 2, 2018 /PRNewswire/ -- Bausch + Lomb, a leading global eye ...
    Bausch + Lomb ULTRA Contact Lenses Get FDA Approval For...Nasdaq
    Valeant Pharma's (VRX) Bausch + Lomb Announces FDA
    ULTRA Contact Lenses Granted FDA Approval for Extended Wear...MD Magazine
    all 3 news articles »

  5. Healio

    Bausch + Lomb initiates OVD clinical trial
    “OVDs play a critical role in ophthalmic surgery, and selection is highly individualized based on clinical surgical requirements and the surgeon's preferences,” Chuck Hess, vice president and general manager of U.S. Surgical at Bausch + Lomb, said in ...


    No Jane Doe: Attorney Can't Hide Identity in Suit Against Bausch & Lomb, Valeant Pharmaceuticals
    Her ruling came in a products liability lawsuit against Irvine, California-based eye health care supplier Bausch & Lomb and Canadian multinational specialty pharmaceutical company Valeant Pharmaceuticals, which has U.S. headquarters in Bridgewater, ...

  7. Bloomberg Big Law Business

    Bausch & Lomb Suit Must ID Law Firm Partner Plaintiff
    Bloomberg Big Law Business
    A law firm partner and her husband can't use pseudonyms in a suit against Bausch & Lomb Inc. related to the lawyer's loss of sight, a federal court in Connecticut said. Concern about economic harm isn't a sufficient reason to conceal their identities ...


    Bausch + Lomb Will Present Scientific And Clinical Research During...
    PR Newswire (press release)
    LAVAL, Quebec, April 27, 2018 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company, and wholly owned subsidiary of Valeant ...
    Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And...Stockhouse

    all 1 news articles »

  9. Healio

    Bausch + Lomb to launch scleral contact lens case
    “The introduction of our new Boston scleral lens case addresses an unmet need of eye care professionals and patients,” John Ferris, general manager, U.S. Vision Care, Bausch + Lomb, said in the release. “Our latest innovation is specifically designed ...

  10. Positive Columnist

    Global Intraocular Lens (IOLs) Market 2018 Evaluation- ALCON, Bausch + Lomb, AMO (Abbott), CARL Zeiss and HOYA
    Exclusive Reportage
    Global Intraocular Lens (IOLs) Market 2018, describes an in-depth evaluation and professional study on the present state of the Intraocular Lens (IOLs) market across the globe. This provides a basic overview of Intraocular Lens (IOLs) market including ...
    Global Intraocular Lens (IOL) Market Competitive Insights 2018: HOYA, CARL Zeiss, Ophtec and Bausch + LombClean Technology
    Intraocular Lens Market Research Report 2018: In-Depth Analysis, Top Key player Johnson & Johnson, Bausch...Technical Progress
    Global Rigid Intraocular Lens Market 2018 – Bausch + Lomb, Biotech Visioncare, SolekoFirst News 24
    Positive Columnist -Investor Opinion
    all 42 news articles »

  11. Healio

    Bausch + Lomb launches Lumify for ocular redness
    Lumify (brimonidine tartrate ophthalmic solution 0.025%) showed a strong safety and efficacy profile in clinical trials, with low risk for rebound redness and 95% symptom improvement seen at 1 minute and lasting up to 8 hours, according to a Bausch + ...